Prostate Cancer

A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force against routine PSA screening for men. Read More

Austin Kirschner, M.D., Ph.D., assistant professor of Radiation Oncology and Cancer Biology, has received the Urology Care Foundation Research Scholars Award for the study of advanced prostate cancer. Read More

Vanderbilt-Ingram Cancer Center (VICC) patient William Ostman smiled while gazing into a camera lens and declared, “I am a prostate cancer survivor.” Read More

Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream. Read More

A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer. Read More

One of the most formidable weapons in a cancer’s arsenal is the ability to spread to other organs. Read More

A gene on chromosome 8 — in a region of the genome linked to risk for many types of cancer — is particularly associated with prostate cancer susceptibility, Vanderbilt University researchers have found. Read More

Researchers at Vanderbilt University Medical Center and the University of Alberta in Canada have identified a biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread. Read More

David Penson, M.D., MPH, professor of Urologic Surgery, has received a $2 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study localized prostate cancer, the second leading cause of death among American men. Read More

A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment. Read More

Antioxidants promote cell growth in a mouse model of prostate cancer, Vanderbilt researchers report in the journal PLoS ONE. The findings provide insight into the recent controversy regarding antioxidants and prostate cancer prevention. Read More

Racial differences exist in quality surgical care, new research from VICC finds. Read More

A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows. Read More

Two proteins that act in opposing directions – one that promotes cancer and one that suppresses cancer — regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found. Read More

Targeting immune system proteins may keep prostate cancer from spreading to bone. Read More

Severity of cancer could be predicted by prostate size. Read More

These days, just about anyone who sees a pink lapel ribbon knows it symbolizes breast cancer awareness. But a light blue ribbon? Well, that’s another story. The symbol for prostate cancer awareness is far less recognizable than its feminine counterpart, just as the disease itself is far less in… Read More

Low blood levels of magnesium are associated with more aggressive prostate cancer, a recent study suggests. Read More

The protein matriptase "cuts" a key component of the prostate tissue barrier and may be involved in prostrate cancer progression, new research finds. Read More